Glenmark Pharmaceuticals
GLENMARK.NS
$12.67
Share price
-1.30%
Change (1 day)
83.89%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $1.23 B
According to Glenmark Pharmaceuticals 's latest financial reports the company's total liabilities are $1.23 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Glenmark Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $1.16 B | 15.16% |
| 2022-03-31 | $1.00 B | -13.28% |
| 2021-03-31 | $1.16 B | 1.76% |
| 2020-03-31 | $1.14 B | 3.14% |
| 2019-03-31 | $1.10 B | -2.97% |
| 2018-03-31 | $1.14 B | 1.7% |
| 2017-03-31 | $1.12 B | 13.46% |
| 2016-03-31 | $0.98 B | -7.52% |
| 2015-03-31 | $1.06 B | 13.57% |
| 2014-03-31 | $0.94 B | 16.64% |
| 2013-03-31 | $0.80 B | 18.84% |
| 2012-03-31 | $0.67 B | -0.08% |
| 2011-03-31 | $0.68 B | 21.12% |
| 2010-03-31 | $0.56 B | 7.36% |
| 2009-03-31 | $0.52 B | 46.28% |
| 2008-03-31 | $0.35 B | 22.76% |
| 2007-03-31 | $0.29 B | 35.36% |
| 2006-03-31 | $0.21 B | 59.51% |
| 2005-03-31 | $0.13 B | 164.6% |
| 2004-03-31 | $50.98 M |